Trials Starting With "I"

IABP-SHOCK II: Randomized comparison of intra-aortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock

      -Trial Overview by Dr. Holger Thiele (ESC 2012)

ICTUS: Invasive versus conservative treatment in unstable coronary syndromes

      -3-Year Follow-Up by Dr. R.J. De Winter (ESC 2006)

      -6-Month Results by Dr. R.J. De Winter (ESC 2004)

IDEAL: Incremental Decrease In End Points through Aggressive Lipid Lowering

      -Trial Overview by Dr. Terje Pedersen (AHA 2005)

      -Background, Study Rationale and Endpoints by the IDEAL Steering Committee and Investigators (2005)

 

Identifying Patients at Risk for Premature Discontinuation of Thienopyridine After Coronary Stent Implantation:

      -Overview by Dr. Alexandre Quadros (CRT 2011)

 

Iliac Artery Stenting: Is There Still a Controversy About Stent Type for TASC C&D Lesions? Insights From COBEST Randomized Trial

      -Overview by Dr. Aravinda Nanjundappa (C3 Complex Intervention Meeting 2011)

ILLUMINATE: Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events

      -Final Results by Dr. Philip J. Barter (AHA 2007)

ILLUSTRATE: Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation

      -Trial Overview by Dr. Steven E. Nissen (ACC 2007)

      -Results by Dr. Steven E. Nissen

      -ILLUSTRATE en espanol by Dr. Steven E. Nissen (ACC 2007) Spanish

IMAGINE: Ichemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme

      -Trial Overview by Dr. W H van Gilst (ESC 2005)

IMMEDIATE: Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care: A Double-Blind Randomized Controlled Trial of Intravenous Glucose, Insulin, and Potassium (GIK) for Acute Coronary Syndromes in Emergency Medical Services

      -Trial Results by Dr. Harry P. Selker (ACC 2012)

 

Impact of Platelet Reactivity When On-treatment With Clopidogrel on Mortality, MI or Stent Thrombosis After PCI: A Collaborative Meta-Analysis of Individual Patient Data

      -Trial Results by Dr. Somjot Brar and Dr. George D. Dangas (ACC 2011)

 

Impact of the Everolimus-Eluting Drug Eluting Stent on Stent Thrombosis: A Meta-Analysis of 13 Randomized Trials

      -Trial Results by Dr. George Dangas (EuroPCR 2011)

 

Impact of Intensive Care Unit Structure on Post-operative Outcomes Following Congenital Heart Surgery: Analysis of a Multi-institutional Database

      -Study Overview by Dr. Sara Pasquali (AHA 2010)

 

Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and Men:

      -Incidence and Prognostic Implications of Stable Angina Pectoris Among Women and Men by Dr. Harry Hemingway

 

Impact of Regional ST-Elevation Myocardial Infarction Systems of Care: On the Use of Protocols and Quality Improvement Initiatives in Community Hospitals Without Cardiac Catheterization Laboratories

      -Overview by Dr. Timothy Henry and Mayme Lou Roettig

 

Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic Stenosis:

      -One-Year Trial Results by Dr. Alexandre Quadros (CRT 2011)

INCITE: INflammatory Cessation with abcIximab or InTEgrilin

      -Trial Overview by Dr. Frederick Welt and Dr. Daniel I. Simon

Incorporating Patient Risk into Decisions Regarding the Optimal Reperfusion Strategy for ST Elevation MI

      -Incorporating Patient Risk into Decisions Regarding the Optimal Reperfusion Strategy for ST Elevation MI by Dr. Duane S. Pinto

INFUSE-AMI: A 2x2 Factorial, Multicenter, Prospective, Randomized Evaluation of Intracoronary Abciximab and Aspiration Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI.

      -Trial Overview by Dr. Gregg W. Stone (ACC 2012)

 

INNOVATE PCI: Intravenous and Oral Elinogrel vs. Clopidogrel as a Novel Antiplatelet Therapy in Patients Undergoing Non-Urgent PCIs

      -Trial Results by Dr. Sunil Rao (ESC 2010)

 

In Stent Restenosis and Late Stent Thrombosis:

      -Overview by Dr. Larry Dean

INTAMI: Integrilin in Acute Myocardial Infarction

      -Early Eptifibatide Improves TIMI 3 Patency Before Primary PCI for Acute STEMI: Results of the INTAMI Pilot Trial by Dr. Uwe Zeymer (April 27, 2005)

INTEGRITI: Integrilin and Tenecteplase in Acute Myocardial Infarction

      -Combination Reperfusion Therapy with Eptifibatide and Reduced-Dose Tenecteplase in Acute Myocardial Infarction:Results from the Phase II Angiographic Trial by Dr. Robert Giugliano

INTERACT: The INTegrelin and Enoxaparin Randomized assessment of Acute Coronary syndrome Treatment Trial

      -Trial Overview by Dr. Shaun G. Goodman (ACC 2002)

Intracoronary Autologous Bone-Marrow Cell Transfer after Myocardial Infarction: A Double-Blind, Randomized, and Placebo-Controlled Clinical Trial

      -Trial Results by Dr. Stefan Janssens (ACC 2005)

INTRINSIC RV: Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs Trial

      -Trial Overview by Dr. Brian Olshansky (Heart Rhythm Society Meeting, May 2006)

INTRO AMI: INTegrilin and Reduced Dose of Thrombolytic in Acute Myocardial Infarction

      -Trial Overview

INVEST: International Verapamil SR - Trandolapril Study

      -Main Outcomes, Predictors of Risk, Diabetes, New Diabetes, BP and Depression/QOL Sub-analyses by Dr. Carl J. Pepine

      -Rethinking Lower Blood Pressure Goals for Diabetic Patients with Coronary Artery Disease by Dr. Rhonda M. Cooper-DeHoff (ACC 2010)

 

I-PRESERVE: Irbesartan in Heart Failure with Preserved EF

      -Trial Overview by Dr. Peter Carson and Dr. Barry Massie

 

ISAR-CABG: Randomized, Superiority Trial of Drug-Eluting-Stent and Bare Metal Stent in Safenous Vein Graft Lesions

      -Trial Overview by Dr. Julinda Mehilli (ACC 2011)

ISAR-DESIRE: Drug-Eluting Stents for In-Stent Restenosis

      -Trial Overview by Dr. Adnan Kastrati (ESC 2004)

ISAR-DESIRE 2: Drug-Eluting Stents For In-Stent Restenosis

      -Prospective, Randomized Trial of Paclitaxel- versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis in Sirolimus-Eluting Stents by Dr. Robert A. Byrne et al. (TCT 2009)

ISAR-DESIRE 3: Drug-Eluting Stents For In-Stent Restenosis

      -Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel Eluting Stents vs. Balloon Angioplasty for Restenosis of "Limus"-Eluting Coronary Stents by Dr. Robert A. Byrne et al. (TCT 2012)

ISAR-DIABETES: Sirolimus-eluting Stent compared with Paclitaxel-eluting stent for Coronary Revascularization

      -Trial Overview by Dr. Adnan Kastrati (ACC 2005)

ISAR Left Main Study: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

      -Trial Overview by Dr. Julinda Mehilli

 

ISAR Left Main 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

      -Trial Overview by Dr. Julinda Mehilli (TCT 2012)

ISAR-REACT: Rapid Early Action for Coronary Treatment

      -ACC 2003 Late-Breaking Clinical Trial Presentation

ISAR-REACT 2: Rapid Early Action for Coronary Treatment

      -Trial Overview by Dr. Adnan Kastrati (ACC 2006)

      -One-year Clinical Outcomes in the ISAR-REACT 2 Trial, a Randomized Comparison of Abciximab Versus Placebo in Patients With non-ST Segment Elevation Acute Coronary Syndromes Undergoing PCI After Pretreatment With Clopidogrel by Dr. M. Seyfarth (ESC 2007)

ISAR-REACT 3: Rapid Early Action for Coronary Treatment

      -Bivalirudin Versus Unfractionated Heparin in Biomarker Negative Patients with Stable and Unstable Angina Undergoing PCI by Dr. Adnan Kastrati (ACC 2008)

ISAR-SWEET

      - Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics by Dr. Julinda Mehilli (AHA 2004)

ISAR-TEST 2

      -Results from a Test of the Efficacy of 3 Limus-Eluting Stents by Dr. Robert A. Byrne (TCT 2007)

ISAR-TEST 3

      -Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis by Dr. Julinda Mehilli

ISAR-TEST 4: Prospective Randomized Trial of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

     -Randomized, Non-inferiority Trial of 3 Limus Agent-Eluting Stents With Different Polymer Coatings by Dr. Julinda Mehilli

     -Two-Year Clinical and Angiographic Outcomes from a Prospective Randomized Trial of Everolimus-Eluting Stents and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease by Dr. Robert A. Byrne (TCT 2010)

 

ISAR-TEST 5: A Prospective Randomized Trial of Polymer-Free Sirolimus-/Probucol-Eluting Stents Compared to Zotarolimus-Eluting Stents in Patients with Coronary Artery Disease

     -Trial Overview by Dr. Julinda Mehilli (TCT 2010)

 

ISSUE 3: Pacemaker Therapy for Patients with Neurally-mediated Syncope and Documented Asystole

     -Trial Overview by Dr. Michele Brignole (ACC 2012)

 

IV ANP in STEMI

      -Effects of Intravenous Atrial Natriuretic Peptide on Cardiac Sympathetic Nerve Activity and Left Ventricular Remodeling in Patients with First Anterior Acute Myocardial Infarction by Dr. Shu Kasama

 

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster